1. Catalog
  2. Medication abortion between 14 0/7 and 27 6/7 week ...
Medication abortion between 14 0/7 and 27 6/7 weeks of gestation
Abortion Clinical practice
This jointly offered on-demand clinical webinar, collaboratively produced by SFP and SMFM, reviews the clinical guidance Medication abortion between 14 0/7 and 27 6/7 weeks of gestation.
Availability
On-Demand
Cost
Free to SFP members.

Not a member but interested in purchasing this course? Please see this activity for purchase on SMFM's online education website.
Credit Offered
1 CME Credit


Physicians: The Society of Family Planning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Society of Family Planning designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

Physician Assistants: Physician Assistants may claim a maximum of 1.0 Category 1 credits for completing this activity. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Other Healthcare Professionals: All non-physician healthcare professionals who complete this accredited activity will receive a certificate documenting completion of the course and associated credit. Many societies and credentialing bodies accept accredited CME activities as long as the topic is relevant to the applicant’s field or discipline.

If you have questions whether this activity meets the education or licensure requirements for your discipline, please consult your licensing or certifying board. You may also contact our Continuing Education team at CME@SocietyFP.org for support.

At the conclusion of this activity, participants will be able to:  
1. Define the best practices for medication abortion between 14 0/7 and 27 6/7 weeks gestation.
2. Discuss the expected patient outcomes for different regimens of medication abortion.
3. Apply recommended considerations when counseling patients between 14 0/7 and 27 6/7 weeks gestation seeking medication abortion.

Instructions for claiming CE credit
To earn continuing education credit and a certificate for completing this course, you must complete the post-webinar evaluation.

Release and expiration dates
CME activity released: February 21, 2024
CME activity expires: February 21, 2027

Acknowledgement of commercial support
No commercial support was received in the production of this activity.

Disclosure summary
The Society of Family Planning asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to activity participants prior to the start of the educational activity. The Society has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

Name Disclosure(s)
 Blake Zwerling, MD, MS  Blake has no financial relationships to disclose. 
 Malavika Prabhu, MD  Malavika receives royalties with UptoDate; Consulting Fees with BabyList, Inc.
 Alison Edleman, MD, MPH  Alison has no financial relationships to disclose. 
 Anwar Jackson, MD, MS  Anwar has no financial relationships to disclose. 
 Anne Burke, MD, MPH  Anne has research with Merck, Exeltis/Chemo; Consulting Fees with Exeltis.
 Audrey Merriam, MD, MS  Audrey has no financial relationships to disclose. 
 Akila Subramaniam, MD   Akila has research with Billion To One; Consulting Fees with Novocuff, Inc.
 Celeste Durnwald, MD  Celeste has research with United Health Group and Helmsley Charitable Trust; Receives royalties with Up To Date; Consulting Fees with Dexcom GDM Advisory Board.
Powered By